Skip to main content

Animations

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    Foundation Outlines Strategies for Improving Clinical Research Recruitment

    NEW YORK - As medical researchers across disease states pursue better treatments, they all share one limiting factor. Estimates hold that 85 percent of all studies face delays and 30 percent never…
    Learn more

  • Default content image

    Crossing the Lines Between Parkinson's and Alzheimer's

    CHICAGO, NEW YORK, TORONTO - As research unveils overlap in the biology -- in addition to long-noted shared clinical symptoms -- of Parkinson's and Alzheimer's diseases, three non-profit…
    Learn more

  • Default content image

    Parkinson's Research Study Shows Inosine Compound Raises Urate Levels

    Potential Neuroprotective Therapy Ready for Next Stage of Development after Michael J. Fox Foundation FundingNew findings published in JAMA Neurology from research into a potentially protective…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Expands Fox Trial Finder to Help Accelerate Parkinson's Trials Worldwide

    Online tool now a global resource to clinical teams and trial volunteersNEW YORK, NY - Today, The Michael J. Fox Foundation for Parkinson's Research (MJFF) launches its clinical research matching…
    Learn more

  • Default content image

    Unique Partnership Lights Up a Parkinson's Disease Research Tool

    The Michael J. Fox Foundation for Parkinson's Research (MJFF), Thomas Jefferson University (Jefferson) and Taconic have collaborated to create, validate and distribute a valuable pre-clinical…
    Learn more

  • Default content image

    The Great Need for Early Diagnostic Tools in the Pursuit of Disease Cures: A Statement from The Michael J. Fox Foundation for Parkinson's Research

    In the field of neurodegeneration, we are closing in on the mechanisms of diseases such as Parkinson's and Alzheimer's, but one big thing is keeping cures at arm's length. We need biomarkers to…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Leads Charge to Develop Alpha-Synuclein PET Tracer to Image Parkinson's Disease Biomarker

    The pursuit of an imaging tool to visualize the protein alpha-synuclein, the hallmark pathology of Parkinson's disease (PD), in the brain is the subject of a paper published today in the&nbsp…
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.